Clopidogrel vs ticlopidine: tolerability after coronary stenting

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2004年 / 1000卷 / 1期
关键词：
Aspirin; Neutropenia; Clopidogrel; Stent Implantation; Ticlopidine;
D O I：
10.2165/00128415-200410000-00006
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [31] Safety of 10 days of ticlopidine after coronary stenting - A randomized comparison with 30 days: Strategic ALternatives with Ticlopidine in Stenting study (SALTS)
    Szto, GYF
    Linnemeier, TJ
    Lewis, SJ
    Punamiya, KK
    Jung, SC
    Rothbaum, DA
    Landin, RJ
    Ball, MW
    Riddell, RV
    Hodes, ZI
    Lips, DL
    Elsner, GB
    Potrikus, M
    Coverdale, JL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 352A - 352A
  • [32] Variable extent of clopidogrel responsiveness in patients after coronary stenting
    Grossmann, R
    Sokolova, O
    Schnurr, A
    Bonz, A
    Porsche, C
    Obergfell, A
    Lengenfelder, B
    Walter, U
    Eigenthaler, M
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (06) : 1201 - 1206
  • [33] Comparison of Low vs Moderate Dose of Atorvastatin in Clopidogrel Resistance After Coronary Stenting in Korean Patients With Acute Coronary Syndrome
    Hong, Soon Jun
    Park, Ji-Young
    Kim, Kyoung-Ah
    Ahn, Chul Min
    Park, Jae Suk
    Kim, Yong Hyun
    Shim, Wan Joo
    Park, Seong Mi
    Lim, Do-Sun
    CIRCULATION JOURNAL, 2009, 73 (06) : 1111 - 1118
  • [34] Efficacy and safety of antiplatelet therapy including ticlopidine after coronary artery stenting
    Namiki, A
    Ishikawa, M
    Nakamura, M
    Yamaguchi, T
    ADVANCES IN CORONARY ARTERY DISEASE, 2001, : 611 - 614
  • [35] Reduction in major adverse cardiac events, including mortality, after stenting using clopidogrel instead of ticlopidine
    Bhatt, DL
    Bertrand, ME
    Berger, PB
    L'Allier, PL
    Moussa, I
    Moses, JW
    Dangas, G
    Taniuchi, M
    Lasala, JM
    Holmes, DR
    Ellis, SG
    Topol, EJ
    CIRCULATION, 2000, 102 (18) : 565 - 566
  • [36] Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting
    De Luca, G
    Suryapranata, H
    van't Hof, AWJ
    Ottervanger, JP
    Hoorntje, JCA
    Gosselink, ATM
    Damibrink, JHE
    Zijlstra, F
    Boer, MJC
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (06) : 1084 - 1089
  • [37] Comparison of platelet inhibition with clopidogrel versus ticlopidine after coronary stent placement.
    Reilly, JP
    Casterella, PJ
    Gallant, EM
    Hann, B
    Woolway, H
    Teirstein, PS
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 10G - 10G
  • [38] Ticlopidine and clopidogrel
    Quinn, MJ
    Fitzgerald, DJ
    CIRCULATION, 1999, 100 (15) : 1667 - 1672
  • [39] Clopidogrel resistance: Implications for coronary stenting
    Gurbel, Paul A.
    Lau, Wei C.
    Bliden, Kevin P.
    Tantry, Udaya S.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (10) : 1261 - 1269
  • [40] After coronary stenting course of ticlopidine (1 month) compared with that of clopidogrel was associated with significantly lower cardiovascular mortality during 28 months follow up
    Gratsianskii, NA
    KARDIOLOGIYA, 2004, 44 (03) : 78 - 80
12345